Engage_BlogImage_1.jpg

First Patient To Receive Gene Editing For Sickle Cell Disease Is Thriving One Year Later

HealthTrust Workforce Solutions on Jul 16, 2020 12:30:00 AM

Sickle CellVictoria Gray is the first person in the U.S. with sickle cell disease to be treated with the revolutionary gene-editing technique called CRISPR. As the one-year anniversary of her landmark treatment approaches, it appears that the billions of genetically modified cells doctors infused into her body are alleviating virtually all the complications of her disorder. "It's wonderful. It's the change I've been waiting on my whole life," Victoria says about the treatment she's received at the Sarah Cannon Research Institute, an HCA Healthcare-affiliated facility located in Nashville, Tenn.

Gray is incredibly thankful for the staff's diligent work and the continuous improvement that is being made to finding a cure. Learn more about her story on NPR.

Topics: Healthcare, Health & Safety

  

Recommended Posts

ENGAGE

Engage is an emerging blog which features relevant, informative and engaging content designed to promote and advance the healthcare industry and the professionals who work within it.

Subscribe to Email Updates

Managing your workforce effectively requires keen insight, operational expertise and a partner who understands healthcare

Start the conversation

Recent Posts